78 related articles for article (PubMed ID: 16687109)
1. [Bacteria to prevent and treat cervical cancer induced by human papillomavirus type 16].
Bermúdez-Humarán L; Langella P
Med Sci (Paris); 2006 May; 22(5):472-3. PubMed ID: 16687109
[No Abstract] [Full Text] [Related]
2. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors.
Bermúdez-Humarán LG; Cortes-Perez NG; Lefèvre F; Guimarães V; Rabot S; Alcocer-Gonzalez JM; Gratadoux JJ; Rodriguez-Padilla C; Tamez-Guerra RS; Corthier G; Gruss A; Langella P
J Immunol; 2005 Dec; 175(11):7297-302. PubMed ID: 16301635
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
Tomson TT; Roden RB; Wu TC
Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945
[TBL] [Abstract][Full Text] [Related]
4. Comparison of six cell penetrating peptides with different properties for in vitro and in vivo delivery of HPV16 E7 antigen in therapeutic vaccines.
Shahbazi S; Bolhassani A
Int Immunopharmacol; 2018 Sep; 62():170-180. PubMed ID: 30015237
[TBL] [Abstract][Full Text] [Related]
5. Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surface.
Ribelles P; Benbouziane B; Langella P; Suárez JE; Bermúdez-Humarán LG
Appl Microbiol Biotechnol; 2013 Feb; 97(3):1231-9. PubMed ID: 23212671
[TBL] [Abstract][Full Text] [Related]
6. New advances in vaccine technology and improved cervical cancer prevention.
Huh WK; Kendrick JE; Alvarez RD
Obstet Gynecol; 2007 May; 109(5):1187-92. PubMed ID: 17470604
[TBL] [Abstract][Full Text] [Related]
7. Current prophylactic and therapeutic uses of a recombinant Lactococcus lactis strain secreting biologically active interleukin-12.
Bermúdez-Humarán LG; Cortes-Perez NG; Ah-Leung S; Lefèvre F; Yang G; Pang Q; Wu C; Zeng Y; Adel-Patient K; Langella P
J Mol Microbiol Biotechnol; 2008; 14(1-3):80-9. PubMed ID: 17957114
[TBL] [Abstract][Full Text] [Related]
8. AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention.
Schwarz TF
Expert Rev Vaccines; 2008 Dec; 7(10):1465-73. PubMed ID: 19053203
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of TRAIL treatment against HPV16 infected cervical cancer cells undergoing senescence following siRNA knockdown of E6/E7 genes.
Eaton S; Wiktor P; Thirstrup D; Lake D; Nagaraj VJ
Biochem Biophys Res Commun; 2011 Feb; 405(1):1-6. PubMed ID: 21167816
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cervical cancer through vaccination of adolescents.
Pichichero ME
Clin Pediatr (Phila); 2006 Jun; 45(5):393-8. PubMed ID: 16891270
[No Abstract] [Full Text] [Related]
11. HSP110 improves the anti-tumor effects of the cytotoxic T lymphocyte epitope E749-57 in mice: HSP110 as a peptide specific chaperone or adjuvant?
Kalos M
Cancer Biol Ther; 2010 Feb; 9(4):333-4. PubMed ID: 20150756
[No Abstract] [Full Text] [Related]
12. The role of human papillomavirus vaccines in cervical neoplasia.
Stern PL; Faulkner R; Veranes EC; Davidson EJ
Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):783-99. PubMed ID: 11563873
[TBL] [Abstract][Full Text] [Related]
13. Papillomavirus-like particle vaccines for cervical cancer.
Schiller JT
Mol Med Today; 1999 May; 5(5):209-15. PubMed ID: 10322313
[TBL] [Abstract][Full Text] [Related]
14. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
[TBL] [Abstract][Full Text] [Related]
15. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
Hantz S; Alain S; Denis F
Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection.
Haigh O; Kattenbelt J; Cochrane M; Thomson S; Gould A; Tindle R
Cancer Gene Ther; 2010 Oct; 17(10):708-20. PubMed ID: 20539319
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer: the second-generation vaccines move forward.
Tuma RS
J Natl Cancer Inst; 2009 Jun; 101(11):774-5. PubMed ID: 19470948
[No Abstract] [Full Text] [Related]
18. Human papillomavirus vaccines.
Stanley MA
Curr Opin Mol Ther; 2002 Feb; 4(1):15-22. PubMed ID: 11883690
[TBL] [Abstract][Full Text] [Related]
19. The tango and tangle of human papillomavirus and the human genome.
Burk RD; DeSalle R
J Natl Cancer Inst; 2006 Aug; 98(15):1026-7. PubMed ID: 16882934
[No Abstract] [Full Text] [Related]
20. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
